These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


63 related items for PubMed ID: 6593823

  • 1. [Immune complexes in the serum of patients with acute myeloblastic leukemia].
    Späth P, Berchtold P, Engler H, Bütler R.
    Schweiz Med Wochenschr; 1984 Oct 06; 114(40):1373-5. PubMed ID: 6593823
    [Abstract] [Full Text] [Related]

  • 2. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G, Bause I, Kneba M, Kehl A, Nagel GA.
    J Clin Lab Immunol; 1984 Jun 06; 14(2):87-92. PubMed ID: 6611419
    [Abstract] [Full Text] [Related]

  • 3. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G, Bloemmen FJ, Ceuppens JL, Stevens EA.
    J Clin Lab Immunol; 1984 Oct 06; 15(2):63-8. PubMed ID: 6335179
    [Abstract] [Full Text] [Related]

  • 4. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L, Glikmann G, Jensenius JC, Svehag SE.
    J Clin Lab Immunol; 1983 Jan 06; 10(1):53-8. PubMed ID: 6338238
    [Abstract] [Full Text] [Related]

  • 5. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
    Rossen RD, Crane MM, Morgan AC, Giannini EH, Giovanella BC, Stehlin JS, Twomey JJ, Hersh EM.
    Cancer Res; 1983 Jan 06; 43(1):422-9. PubMed ID: 6600161
    [Abstract] [Full Text] [Related]

  • 6. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
    Rossen RD, Zubler RH, Day NK, Reisberg MA, Morgan AC, Gutterman JU, Hersh EM.
    J Lab Clin Med; 1978 Feb 06; 91(2):191-204. PubMed ID: 413872
    [Abstract] [Full Text] [Related]

  • 7. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
    Schmidt R, Walther S, Sodomann CP.
    Immunobiology; 1982 Feb 06; 162(2):153-64. PubMed ID: 6981581
    [Abstract] [Full Text] [Related]

  • 8. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
    Starkebaum G, Arend WP, Nardella FA, Gavin SE.
    J Lab Clin Med; 1980 Aug 06; 96(2):238-51. PubMed ID: 6772719
    [Abstract] [Full Text] [Related]

  • 9. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD, Hasz DE.
    J Clin Lab Immunol; 1982 Nov 06; 9(2):121-31. PubMed ID: 6984078
    [Abstract] [Full Text] [Related]

  • 10. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
    Shepherd PS.
    Clin Exp Immunol; 1979 May 06; 36(2):250-5. PubMed ID: 477028
    [Abstract] [Full Text] [Related]

  • 11. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME.
    J Lab Clin Med; 1982 May 06; 99(5):678-92. PubMed ID: 6978370
    [Abstract] [Full Text] [Related]

  • 12. Effect of C1q on the processing of immune complexes by human neutrophils.
    Ohkuro M, Kobayashi K, Takahashi K, Nagasawa S.
    Immunology; 1994 Nov 06; 83(3):507-11. PubMed ID: 7835978
    [Abstract] [Full Text] [Related]

  • 13. The detection of circulating immune complexes in normal subjects using four different methods.
    Di Mario U, Guy K, Irvine WJ.
    J Clin Lab Immunol; 1981 Mar 06; 5(2):95-9. PubMed ID: 6971334
    [Abstract] [Full Text] [Related]

  • 14. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM, Moore M, Hilton AM.
    Clin Exp Immunol; 1981 Jul 06; 45(1):18-28. PubMed ID: 6975678
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W, Amlot PL, Williams BD.
    Clin Exp Immunol; 1982 Jun 06; 48(3):705-14. PubMed ID: 6811171
    [Abstract] [Full Text] [Related]

  • 16. Detection of immune complexes in serum of dogs with neoplastic disease by solid-phase C1q binding, using an enzyme-linked immunosorbent assay.
    DeBoer DJ, Madewell BR.
    Am J Vet Res; 1983 Sep 06; 44(9):1710-3. PubMed ID: 6605101
    [Abstract] [Full Text] [Related]

  • 17. Improved standardization in the quantitative estimation of soluble immune complexes making use of an international reference preparation. Results of a collaborative multicentre study.
    Nydegger UE, Svehag SE.
    Clin Exp Immunol; 1984 Nov 06; 58(2):502-9. PubMed ID: 6499284
    [Abstract] [Full Text] [Related]

  • 18. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
    Kauffmann RH, Herrmann WA, Meijer CJ, Daha MR, Vanes LA.
    Clin Exp Immunol; 1980 Sep 06; 41(3):459-70. PubMed ID: 7438561
    [Abstract] [Full Text] [Related]

  • 19. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM, van Es LA, Westedt ML, Daha MR.
    J Clin Lab Immunol; 1984 Jun 06; 14(2):73-9. PubMed ID: 6748049
    [Abstract] [Full Text] [Related]

  • 20. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM, Moore M.
    Clin Exp Immunol; 1983 May 06; 52(2):407-16. PubMed ID: 6602679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.